No insider purchase over the last 90 days. The latest, by 株式会社UH Partners 3, was filed 09 May 2024.
DVx Inc.: what insiders have been doing
This page follows insider dealings at DVx Inc. as filed with EDINET (Japan FSA), a company from the Health Care sector. The last twelve months, up to 8 November 2026, brought 1 filing signed by 1 insider.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of DVx Inc. for at least a year.
Compared with its exchange (3,205 companies, median 3 filings), a count of 1 filing is below the norm. Looking back to 2021, when coverage begins, insiders filed 128 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 0.9% of flowShareXTKSEDINET:S100XRW2
- 1.0% of flowShareXTKSEDINET:S100WQG3
- 6.4% of flowShareXTKSEDINET:S100WMOY
- 6.7% of flowShareXTKSEDINET:S100VR7U
- 6.9% of flowShareXTKSEDINET:S100VDY2
- 6.7% of flowShareXTKSEDINET:S100UJ2S
- 6.5% of flowShareXTKSEDINET:S100TCLQ
- 1,300 sharesShareXTKSEDINET:S100TCLQ:T1Canonical exit: 2 Jun 2024 (T+90)
- 1,900 sharesShareXTKSEDINET:S100TCLQ:T2Canonical exit: 3 Jun 2024 (T+90)
- 700 sharesShareXTKSEDINET:S100TCLQ:T3Canonical exit: 4 Jun 2024 (T+90)
- 2,200 sharesShareXTKSEDINET:S100TCLQ:T4Canonical exit: 5 Jun 2024 (T+90)
- 900 sharesShareXTKSEDINET:S100TCLQ:T6Canonical exit: 6 Jun 2024 (T+90)
- 1,000 sharesShareXTKSEDINET:S100TCLQ:T7Canonical exit: 9 Jun 2024 (T+90)
- 700 sharesShareXTKSEDINET:S100TCLQ:T8Canonical exit: 10 Jun 2024 (T+90)
- 500 sharesShareXTKSEDINET:S100TCLQ:T9Canonical exit: 11 Jun 2024 (T+90)
- 2,600 sharesShareXTKSEDINET:S100TCLQ:T10Canonical exit: 12 Jun 2024 (T+90)
- 400 sharesShareXTKSEDINET:S100TCLQ:T11Canonical exit: 13 Jun 2024 (T+90)
- 1,200 sharesShareXTKSEDINET:S100TCLQ:T12Canonical exit: 16 Jun 2024 (T+90)
- 1,100 sharesShareXTKSEDINET:S100TCLQ:T13Canonical exit: 17 Jun 2024 (T+90)
- 2,400 sharesShareXTKSEDINET:S100TCLQ:T14Canonical exit: 19 Jun 2024 (T+90)
- 100 shares@ JP¥1,079.99670.3% of flowShareXOFFEDINET:S100TCLQ:T15Canonical exit: 19 Jun 2024 (T+90)
- 1,700 sharesShareXTKSEDINET:S100TCLQ:T16Canonical exit: 20 Jun 2024 (T+90)
- 2,400 sharesShareXTKSEDINET:S100TCLQ:T17Canonical exit: 23 Jun 2024 (T+90)
- 2,600 sharesShareXTKSEDINET:S100TCLQ:T18Canonical exit: 24 Jun 2024 (T+90)
- 4,800 sharesShareXTKSEDINET:S100TCLQ:T19Canonical exit: 25 Jun 2024 (T+90)
25 of 178 declarations
About DVx Inc.
DVX Corporation is a company listed on the XTKS market, specializing in the health and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
